What BIOSS Centre for Biological Signalling Studies does

BIOSS Centre for Biological Signalling Studies is a publicly funded research centre hosted at Albert-Ludwigs-Universität Freiburg in Freiburg, Germany. Founded in 2007 through the German Research Foundation's (DFG) Excellence Strategy as a Cluster of Excellence and renewed in 2012, the centre transitioned in 2019 to sustainable institutional funding from the University of Freiburg and the Ministry of Science and Education (MWK) of Baden-Württemberg. BIOSS applies modern analytical methods and synthetic/chemical biology strategies to study how cells communicate and adapt to environmental influences, operating under the maxim "From analysis to synthesis – spanning all domains of life."

The centre is structured around three research areas (BIOSS Area A, B, and C) and is supported by the Signalhaus research facility and the Core Facilities Signalling Campus, which provide shared infrastructure (imaging, genomics, proteomics) to more than 100 collaborating research groups. Active research lines include synthetic immunology with CAR-T cell engineering for cancer, bladder cancer epigenetics (UcarE DFG research unit), living materials with homeostatic capability (STEADY project), and safer leukemia therapies after stem cell transplantation. The centre does not sell commercial products or services and has no disclosed pricing model.

BIOSS functions under a non-commercial, community-led go-to-market: it serves academic researchers, graduate students, postdocs, and clinical researchers through collaborative research, training programs (notably via SGBM), shared infrastructure, and scientific publication. Its revenue base is grant funding (DFG, ERC Advanced Grants, Heisenberg Professorship) layered on top of core institutional support from the University of Freiburg and MWK Baden-Württemberg, with strategic partners including CIBSS, MPI-IE, RWTH Aachen, University of Tübingen, and Harvard Medical School.

Name

BIOSS Centre for Biological Signalling Studies

Legal name

BIOSS Centre for Biological Signalling Studies

Website

https://bioss.uni-freiburg.de

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

BIOSS Centre for Biological Signalling Studies is a publicly funded university research centre in Freiburg, Germany, using synthetic and chemical biology to study cellular signalling across all domains of life. It serves academic and clinical researchers through shared infrastructure, training, and collaborative programmes.

Ownership category

akta.pro rank

Product category

Academic Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)

akta.pro secondary industry

Proteomics & Biomarker Analytical Testing (HLAGADAG)

Keywords

• Biological signalling research
• Academic research services
• Core research facilities
• Synthetic biology studies
• Graduate life science training

Headquarters

HQ city

Freiburg

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Government Research Funding: BIOSS was originally funded by the German Research Foundation (DFG) through its Excellence Strategy as a cluster of Excellence from 2007-2018. From 2019 onwards, the centre is sustainably funded by the University of Freiburg and the Ministry of Science and Education (MWK) of the State of Baden-Württemberg.
2. Research Services: The centre provides research infrastructure and services to the life science community through its Core Facilities Signalling Campus

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

BIOSS is a university research centre at Albert-Ludwigs-Universität Freiburg that conducts interdisciplinary biological signalling research spanning all domains of life, organised across three research areas (Area A, B, C). It provides shared research infrastructure through the Signalhaus building and Core Facilities Signalling Campus, and delivers research services and training to the life science community.

Product overview

BIOSS Centre for Biological Signalling Studies is a university research centre, not a commercial product company. It operates as a cluster of excellence at the University of Freiburg, offering a unified research programme rather than commercial products. The centre is structured around three research areas (BIOSS Area A, B, and C), housed within the Signalhaus research building, supported by Core Facilities Signalling Campus. The centre provides research services, training, and infrastructure to the life science community through its interdisciplinary biological signalling research programme, funded sustainably by the University of Freiburg and the Ministry of Science and Education of Baden-Württemberg.

Differentiator

Problem solved

Functional benefit

Products and services

• BIOSS Area A Research Program
• BIOSS Area B Research Program
• BIOSS Area C Research Program
• Signalhaus Research Infrastructure
• Core Facilities Signalling Campus

Quantifiable outcome

• More than 100 research groups from different disciplines collaborate on signalling science
• +1 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Spemann Graduate School of Biology and Medicine (SGBM)coreStrategic or Co-development PartnerSGBM is a graduate school at University of Freiburg focused on biology and medicine research training. BIOSS is closely associated with SGBM and shares board membership with the graduate school.
• Max Planck Institute of Immunobiology and Epigenetics (MPI-IE)coreStrategic or Co-development PartnerMPI-IE is a partner institute collaborating with BIOSS on immunology and epigenetics research. Both institutions are part of the Freiburg research ecosystem.
• CIBSS - Centre for Integrative Biological Signalling StudiescoreStrategic or Co-development PartnerCIBSS is the sister centre to BIOSS, also housed in the Signalhaus building. Both centres collaborate on joint events like open days and share research infrastructure. Together they include more than 100 research groups.
• University of FreiburgcoreStrategic or Co-development PartnerBIOSS is a centre of the University of Freiburg. The university provides sustainable funding along with MWK Baden-Württemberg since 2019. BIOSS is hosted within the university's Institute of Biology III.
• RWTH Aachen UniversityminorStrategic or Co-development PartnerPartner university in the DFG-funded UcarE research unit on bladder cancer, working alongside University of Freiburg and University of Tübingen.
• University of TübingenminorStrategic or Co-development PartnerPartner university in the DFG-funded UcarE research unit on bladder cancer, collaborating with University of Freiburg and RWTH Aachen University.
• Herdern Citizens' AssociationminorOthersLocal community organisation that supported the joint open day event of CIBSS and BIOSS, representing local residents interested in the research activities in their neighbourhood.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• CIBSS - Centre for Integrative Biological Signalling Studies: BIOSS's sister centre within the University of Freiburg, sharing the Signalhaus facility and collaborating on joint research and outreach. CIBSS is the most direct peer, operating in the same niche of biological signalling research with overlapping infrastructure and faculty.
• Max Planck Institute of Immunobiology and Epigenetics (MPI-IE): Partner institute collaborating with BIOSS on immunology and epigenetics research, also located in Freiburg. Operates a similar research-centred model with overlapping scientific scope in cellular signalling and immunology.

Broad incumbents

• Whitehead Institute for Biomedical Research: MIT-affiliated non-profit research organization focused on biomedical research. Comparable in its academic research-only model, technology platforms, and emphasis on fundamental discoveries in cell biology and immunology.
• Wellcome Sanger Institute: UK-based genomic and cellular biology research institute with shared research infrastructure. Operates a similar publicly-funded research model with core facilities serving an international scientific community.
• German Cancer Research Center (DKFZ): Germany's largest biomedical research institute, working on cancer biology and immunology. Comparable as a major publicly-funded German research organization with overlapping interests in signalling pathways and cancer immunotherapy research (e.g., CAR-T).
• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in molecular life sciences with multiple sites. Comparable to BIOSS in its focus on molecular biology research, use of advanced core facilities, and internationally collaborative research model.
• Scripps Research Institute: Major US non-profit research organization focused on biomedical sciences, with strong publication output and grant capture comparable to BIOSS's academic profile. Focuses on chemical biology, immunology, and cell signalling.
• Helmholtz Centre for Infection Research (HZI): Large German government-funded research centre conducting research on infection biology and immunology. Comparable in scale and funding model to BIOSS, with broader portfolio but overlapping areas in cell signalling and immune system research.

Regional players

• Leibniz Institute for Immunotherapy (LIT): German research institute focused on immunology and immunotherapy, including CAR-T cell technologies. Operates a similar publicly-funded model with closer alignment to BIOSS's synthetic immunology research themes.
• Institute of Molecular Biology (IMB) Mainz: German research institute focused on epigenetics, DNA repair, and quantitative and computational biology. Operates a similar model of publicly-funded, advanced molecular biology research comparable to BIOSS's research scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOSS Centre for Biological Signalling Studies